The underlying mechanism of gut microbiota alteration, ACE2 expression level, dysbiosis, and gut-lung axis among CD cases with COVID-19 infection is still unclear, and there is no published clinical data on the regulation of gut microbiota in CD patients as a treatment of COVID-19. The gene discussed is ACE2; the disease is COVID-19.